60/100B82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
GE HealthCare Technologies debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
GE HealthCare Technologies's debt to equity ratio is 0.90: total debt of 10.41B USD against shareholders' equity of 11.61B USD.
- Today
- 0.90
- Average, 5 years
- 1.16
- Low, 5 years
- 0.90
- High, 5 years
- 1.53
Debt to equity = total debt ÷ shareholders' equity = 10.41B ÷ 11.61B = 0.90
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.90 | 10.41B | 11.61B | |
| FY2025 | 31 Dec 2025 | 0.96 | 10.00B | 10.38B |
| FY2024 | 31 Dec 2024 | 1.11 | 9.38B | 8.45B |
| FY2023 | 31 Dec 2023 | 1.38 | 9.86B | 7.13B |
| FY2022 | 31 Dec 2022 | 0.92 | 8.64B | 9.36B |
| FY2021 | 31 Dec 2021 | 0.03 | 437.00M | 16.66B |
| FY2020 | 31 Dec 2020 | 0.03 | 468.00M | 14.73B |
| FY2019 | 31 Dec 2019 | — | — | — |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.90 | 10.41B | 11.61B |
| Q2 FY2026 | 30 Jun 2026 | 0.92 | 10.09B | 10.98B |
| Q1 FY2026 | 31 Mar 2026 | 0.99 | 10.58B | 10.67B |
| Q4 FY2025 | 31 Dec 2025 | 0.96 | 10.00B | 10.38B |
| Q3 FY2025 | 30 Sept 2025 | 1.08 | 10.74B | 9.99B |
| Q2 FY2025 | 30 Jun 2025 | 1.12 | 10.84B | 9.71B |
| Q1 FY2025 | 31 Mar 2025 | 1.00 | 9.18B | 9.19B |
| Q4 FY2024 | 31 Dec 2024 | 1.11 | 9.38B | 8.45B |
| Q3 FY2024 | 30 Sept 2024 | 1.29 | 10.73B | 8.32B |
| Q2 FY2024 | 30 Jun 2024 | 1.24 | 9.66B | 7.80B |
| Q1 FY2024 | 31 Mar 2024 | 1.31 | 9.67B | 7.41B |
| Q4 FY2023 | 31 Dec 2023 | 1.38 | 9.86B | 7.13B |
| Q3 FY2023 | 30 Sept 2023 | 1.44 | 10.26B | 7.13B |
| Q2 FY2023 | 30 Jun 2023 | 1.44 | 10.24B | 7.10B |
| Q1 FY2023 | 31 Mar 2023 | 1.53 | 10.24B | 6.69B |
| Q4 FY2022 | 31 Dec 2022 | 0.92 | 8.64B | 9.36B |
| Q3 FY2022 | 30 Sept 2022 | — | — | — |
| Q2 FY2022 | 30 Jun 2022 | — | — | — |
| Q1 FY2022 | 31 Mar 2022 | — | — | — |
| Q4 FY2021 | 31 Dec 2021 | — | — | — |
| Q3 FY2021 | 30 Sept 2021 | — | — | — |
| Q2 FY2021 | 30 Jun 2021 | — | — | — |
| Q1 FY2021 | 31 Mar 2021 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Current ratio,All ratios
Common questions about GE HealthCare Technologies's debt to equity
Source: Financial Modeling Prep